期刊文献+

国产牛肺表面活性剂治疗早产儿呼吸窘迫综合征的疗效观察 被引量:13

Clinical observation on domestic pulmonary surfactant in treatment of neonatal respiratory distress syndrome in preterm infants
下载PDF
导出
摘要 目的探讨国产牛肺表面活性剂(珂立苏)治疗早产儿呼吸窘迫综合征(NRDS)的临床疗效及安全性。方法将85例患新生儿呼吸窘迫综合征的早产儿分为对照组38例及治疗组47例,对照组给予鼻塞持续气道正压通气,治疗组给予鼻塞持续气道正压通气与珂立苏联合应用,比较两组的临床疗效。结果治疗组患儿总有效率为85.11%,明显高于对照组的65.79%,二者差异有统计学意义(P<0.05)。治疗后2小时两组患儿血气指标较治疗前均明显好转(P<0.01),但治疗组患儿改善更明显(P<0.01)。治疗组患儿临床症状缓解和机械通气时间较对照组缩短,差异有统计学意义(P<0.05)。治疗组患儿肺部急慢性并发症发生率为23.40%(11/47例),明显低于对照组的44.74%(17/38例,P<0.05)。结论国产牛肺表面活性剂治疗早产儿呼吸窘迫综合征安全有效,联合鼻塞持续气道正压通气可显著提高临床疗效,改善血气指标,缓解临床症状和缩短机械通气时间,值得临床推广应用。 Objective To investigate the clinical effect and safety of domestic pulmonary surfactant (PS) in treatment of neonatal respiratory distress syndrome (NRDS) in preterm infants.Methods Eighty five preterm infants with NRDS were divided into treatment and control groups,nasal continuous positive airway pressure (NCPAP) was used in control group thirty-eight infants.NCPAP combined with domestic PS were used in treatment group forty-seven infants,clinical curative effect of the two groups were compared.Results The total effective rate of the treatment group was 85.11%,which was significantly higher than that of control group (65.79 %),and the difference was significant (P〈0.05).After two hours with the therapies,the blood gas analysis indexes of both groups were significantly improved when compared with those before the treatments (P〈0.01),but those of the treatment group were improved more significantly (P 〈0.01).The time of clinical symptom relief and mechanical ventilation in the treatment group was shorter than that of the control group (P〈0.05).The incidence of acute and chronical pulmonary complication was lower than that of control group (23.40% vs 44.74%,P〈0.05).Conclusion Domestic PS was safe and effective in treatment NRDS in preterm infants,PS combined with NCPAP in treatment of NRDS significantly elevates the clinical therapeutic effects,improves blood gas indexes,shortens the time of clinical smptom relief and mechanical ventilation and reduces the incidence of complications.
出处 《西部医学》 2013年第12期1802-1804,1807,共4页 Medical Journal of West China
关键词 早产儿呼吸窘迫综合征 鼻塞持续气道正压通气 肺表面活性物质 Neonatal respiratory distress syndrome Nasal continuous positive airway pressure pulmonary surfactant Preterm infant
  • 相关文献

参考文献10

  • 1邵肖梅;叶鸿瑁;丘小汕.实用新生儿学[M]北京:人民卫生出版社,2011395-398.
  • 2沈晓明;王卫平.儿科学[M]北京:人民卫生出版社,2007111-115.
  • 3Xiaojuan YIN,Lihua LI,Hanxiao FAN. Correlation between surfactant protein B mRNA expression and neonatal respiratory distress syndrome[J].Experimental and therapeutic medicine,2012,(05):815-819.
  • 4卢维城,向伟,吴明,郑旭,林静,陈兴月,魏海波,詹端,李春蕾.肺表面活性物质蛋白B基因多态性与新生儿呼吸窘迫综合征易感性的相关性研究[J].中国当代儿科杂志,2012,14(1):24-27. 被引量:26
  • 5Sweet DG,Carnielli V,Greisen G. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2013 update[J].Neonatology,2013,(04):353-368.
  • 6黄西林,陈丹,李小萍,李明玉,沈剑锋,吴晓松.INSURE策略治疗新生儿呼吸窘迫综合征的临床研究[J].中国当代儿科杂志,2013,15(1):9-13. 被引量:43
  • 7Bahadue FL,Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome[J].{H}Cochrane Database of Systematic Reviews,2012,(11):CD001456.
  • 8J Wells Logan,Fernando R Moya. Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome:summary of clinical trials[J].Therapeutics and Clinical Risk Management,2009,(01):251-260.
  • 9刘云,李丽,梁文英,聂春霞.不同种类肺表面活性物质治疗新生儿呼吸窘迫综合征的疗效比较[J].中国当代儿科杂志,2012,14(4):253-255. 被引量:22
  • 10Soll R,Ozek E. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome[J].{H}Cochrane Database of Systematic Reviews,2009,(01):CD000141.

二级参考文献38

共引文献86

同被引文献102

  • 1李强,祝鸣春.新生儿呼吸窘迫综合征的X线分析[J].实用放射学杂志,2005,21(4):431-432. 被引量:5
  • 2刘红萍,董晓菲,田争.高频通气山莨菪碱救治儿童急性呼吸窘迫综合征[J].湖南中医药大学学报,2011,31(10):15-16. 被引量:1
  • 3初桂兰,王静,辛玥,郑军,郑荣秀,毕道濯.预防性应用表面活性剂对新生儿呼吸窘迫综合征防治的研究[J].中华医学杂志,2006,86(13):876-880. 被引量:31
  • 4邵肖梅,叶鸿瑶,丘小汕.实用新生儿学[M].4版.北京:人民卫生出版社,2011:807-808.
  • 5廖承德,张林,刘晓梅,张渝华,李红丽.小儿麻疹合并肺炎的临床及胸部X线分析[J].实用放射学杂志,2007,23(11):1526-1528. 被引量:8
  • 6赵云秋浅谈急性呼吸窘迫综合征的X线诊断及鉴别诊断(附35例X线分析)[J].求医问药(学术版),2012,10(2):79-80.
  • 7杜海燕.肺部疾病的x线分析与诊断[J].中外健康文摘,2011,08(11):160-161.
  • 8Nakahara H, Lee S, Sugihara G, et al. Langmuir monolayer of artifi- cial pulmonary surfactant mixtures with an amphiphilic peptide at the air/water interface: comparison of new preparations with surfae- ten (Surfactant TA) [J]. Langmuir, 2008, 24(7): 3370-3379.
  • 9Lukovic D, Plaseneia I, Tabemer FJ, et al. Production and character- isation of recombinant forms of human pulmonary surfactant pro- tein C (SP-C): Slructure and surface activity [J]. Biochim Biophys Acta, 2006, 1758(4): 509-518.
  • 10MuUowney T, Manson D, Kim R, et al. Primary ciliary dyskinesia and neonatal respiratory distress [J]. Pediatrics, 2014, 134(6): 1160-1166.

引证文献13

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部